Long-term effect of bezafibrate on parameters of hepatic fibrosis in primary biliary cirrhosis.
Ohmoto
Kenji
K
Yoshioka
Naoko
N
Yamamoto
Shinichiro
S
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001629:Bezafibrate / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008103:Liver Cirrhosis / Q000503:physiopathology*; D008105:Liver Cirrhosis, Biliary / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D001629:Bezafibrate